ACP Journal Club. Apixaban was noninferior to enoxaparin plus warfarin in patients with acute venous thromboembolism - PubMed

Comment

ACP Journal Club. Apixaban was noninferior to enoxaparin plus warfarin in patients with acute venous thromboembolism

Thomas Deloughery. Ann Intern Med. 2013.

Comment on

• Oral apixaban for the treatment of acute venous thromboembolism.

  Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI; AMPLIFY Investigators. Agnelli G, et al. N Engl J Med. 2013 Aug 29;369(9):799-808. doi: 10.1056/NEJMoa1302507. Epub 2013 Jul 1. N Engl J Med. 2013. PMID: 23808982 Clinical Trial.

Similar articles

• [Apixaban for treatment of acute venous thromboembolism].

  Steurer J. Steurer J. Praxis (Bern 1994). 2013 Oct 30;102(22):1387. doi: 10.1024/1661-8157/a001457. Praxis (Bern 1994). 2013. PMID: 24169485 German. No abstract available.

• Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial.

  Cohen AT, Agnelli G, Buller HR, Gallus A, Raskob GE, Sanders P, Thompson J, Weitz JI. Cohen AT, et al. Thromb Haemost. 2019 Mar;119(3):461-466. doi: 10.1055/s-0038-1676983. Epub 2019 Jan 16. Thromb Haemost. 2019. PMID: 30650446 Clinical Trial.

• [Oral apixaban for the treatment of acute venous thromboembolism].

  Millán Longo C. Millán Longo C. Rev Clin Esp (Barc). 2014 Apr;214(3):164. doi: 10.1016/j.rce.2013.11.003. Rev Clin Esp (Barc). 2014. PMID: 24829948 Spanish. No abstract available.

• Apixaban: a novel oral inhibitor of factor Xa.

  Nutescu E. Nutescu E. Am J Health Syst Pharm. 2012 Jul 1;69(13):1113-26. doi: 10.2146/ajhp110418. Am J Health Syst Pharm. 2012. PMID: 22722590 Review.

• Drug Treatment of Venous Thromboembolism in the Elderly.

  Boey JP, Gallus A. Boey JP, et al. Drugs Aging. 2016 Jul;33(7):475-90. doi: 10.1007/s40266-016-0378-x. Drugs Aging. 2016. PMID: 27255713 Review.

Cited by

• Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism.

  Li M, Li J, Wang X, Hui X, Wang Q, Xie S, Yan P, Tian J, Li J, Xie P, Yang K, Yao L. Li M, et al. Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD010957. doi: 10.1002/14651858.CD010957.pub3. Cochrane Database Syst Rev. 2023. PMID: 37057837 Free PMC article. Review.

• Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis.

  Wang X, Ma Y, Hui X, Li M, Li J, Tian J, Wang Q, Yan P, Li J, Xie P, Yang K, Yao L. Wang X, et al. Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD010956. doi: 10.1002/14651858.CD010956.pub3. Cochrane Database Syst Rev. 2023. PMID: 37058421 Free PMC article. Review.

• Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism.

  Robertson L, Kesteven P, McCaslin JE. Robertson L, et al. Cochrane Database Syst Rev. 2015 Dec 4;2015(12):CD010957. doi: 10.1002/14651858.CD010957.pub2. Cochrane Database Syst Rev. 2015. PMID: 26636644 Free PMC article. Updated. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information